BNP Paribas Financial Markets Raises Stock Holdings in Corteva, Inc. $CTVA

BNP Paribas Financial Markets boosted its stake in Corteva, Inc. (NYSE:CTVA) by 13.4% during the 4th quarter, Holdings Channel reports. The institutional investor owned 1,188,069 shares of the company’s stock after acquiring an additional 140,030 shares during the period. BNP Paribas Financial Markets’ holdings in Corteva were worth $79,636,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of CTVA. JPL Wealth Management LLC purchased a new stake in Corteva in the 3rd quarter valued at about $25,000. Redmont Wealth Advisors LLC purchased a new stake in Corteva in the 3rd quarter valued at about $29,000. Jackson Grant Investment Advisers Inc. raised its holdings in Corteva by 90.6% in the 3rd quarter. Jackson Grant Investment Advisers Inc. now owns 448 shares of the company’s stock valued at $30,000 after buying an additional 213 shares during the period. Basepoint Wealth LLC purchased a new stake in Corteva in the 4th quarter valued at about $30,000. Finally, KERR FINANCIAL PLANNING Corp purchased a new stake in Corteva in the 3rd quarter valued at about $33,000. 81.54% of the stock is currently owned by hedge funds and other institutional investors.

Corteva Stock Performance

Shares of CTVA opened at $77.71 on Tuesday. The stock has a 50 day moving average price of $81.32 and a 200 day moving average price of $74.68. The company has a quick ratio of 1.03, a current ratio of 1.47 and a debt-to-equity ratio of 0.07. The company has a market capitalization of $51.98 billion, a price-to-earnings ratio of 45.71, a price-to-earnings-growth ratio of 2.39 and a beta of 0.59. Corteva, Inc. has a 52-week low of $60.53 and a 52-week high of $85.63.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 earnings per share for the quarter, beating the consensus estimate of $1.18 by $0.32. The business had revenue of $4.91 billion during the quarter, compared to the consensus estimate of $4.64 billion. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The company’s revenue was up 11.0% compared to the same quarter last year. During the same period in the prior year, the company earned $1.13 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Research analysts predict that Corteva, Inc. will post 3.72 EPS for the current fiscal year.

Corteva Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 15th. Stockholders of record on Monday, June 1st will be issued a $0.18 dividend. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend is Monday, June 1st. Corteva’s dividend payout ratio is presently 42.35%.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on CTVA. CICC Research boosted their price objective on shares of Corteva from $80.00 to $93.00 and gave the company an “outperform” rating in a report on Wednesday, May 13th. BNP Paribas Exane boosted their price target on shares of Corteva from $74.00 to $77.00 in a research note on Wednesday, May 6th. Rothschild & Co Redburn boosted their price target on shares of Corteva from $80.00 to $90.00 and gave the stock a “neutral” rating in a research note on Wednesday, April 29th. Jefferies Financial Group boosted their price target on shares of Corteva from $95.00 to $97.00 in a research note on Thursday, May 7th. Finally, Morgan Stanley boosted their price target on shares of Corteva from $84.00 to $95.00 and gave the stock an “overweight” rating in a research note on Thursday. Fourteen investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $88.67.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid?2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.